The field of vaccinology has entered a transformative era. We have moved far beyond the traditional “isolate, inactivate, and inject” methodology. Today, building a vaccine candidate is more akin to high-level molecularRead More…
“We have the drugs, but the parasite is learning faster than we are.” This blunt warning from a parasitology lab in Northeast India sums up the quiet crisis surrounding Fasciolopsis buski—a flatwormRead More…
Recently, the journal Nature Biomedical Engineering published a research paper titled “Dendritic-cell-targeting virus-like particles as latent mRNA vaccine carriers” about a new vaccine platform technology that can specifically target dendritic cells (DCs)Read More…
Therapeutic tumor cells (ThTCs) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This strategy has been proven to induce an anti-tumor immune responseRead More…